Shots:

• Qiagen launches QuantiFERON SARS-CoV-2 RUO solution that detects T-cell responses of the human immune system to the pathogen for COVID-19
• Studies suggested that T-cell response to SARS-CoV-2 declines more slowly than Ab response presenting benefits to a researcher who wants to push beyond the existing detection of active infections to screen for potential courses of the illness and long-term immune responses to it
• QuantiFERON SARS-CoV-2 RUO is a flexible- modular system designed to meet a wide range of research demands and is based on QuantiFERON technology

 ­ Ref: Businesswire | Image: Qiagen Corporate